The emerging patent landscape of CRISPR–Cas gene editing technology

NATURE BIOTECHNOLOGY(2016)

Cited 71|Views14
No score
Abstract
Early views on the control of the CRISPR–Cas disruptive enabling technology and access for follow-on commercial applications.
More
Translated text
Key words
Intellectual-property rights,RNAi,Life Sciences,general,Biotechnology,Biomedicine,Agriculture,Biomedical Engineering/Biotechnology,Bioinformatics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined